News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Diasome Pharmaceuticals Adds Diabetes Experts to Board of Directors
June 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, today announced the addition of Arthur H. Rubenstein, MBBCh, and G. Alexander (Zan) Fleming, MD, to the company’s Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Manufacturing
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
May 14, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Bayer, Leap, Atara Reduce Workforces Amid Strategic Reorganizations
May 14, 2025
·
204 min read
·
BioSpace Editorial Staff
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
May 14, 2025
·
2 min read
·
Heather McKenzie
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong
